Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Non-Tech : Bill Wexler's Dog Pound -- Ignore unavailable to you. Want to Upgrade?

To: Bill Wexler who wrote (1782)	7/8/1999 2:54:00 PM
From: Dale Baker	Respond to of 10293

If GUMM has a prevention or cure for the common cold, you tend to think they would be trading a shade higher than $11. Seems a little bit out of whack to me.

To: Bill Wexler who wrote (1782)	7/8/1999 3:16:00 PM
From: JDN	Respond to of 10293

Dear Bill: Yes, I agree everything seems to hinge on that gum related to the common cold in the Zicam Deal. However, they seem to be saying they expect it in a lot of stores this fall. You know, the name of the game is exposure. If they get the distribution I presume it will be a success if not then down the tubes most likely. Personally, I happen to be a believer in and user of Alternative medicines myself so that doesnt bother me. JDN

To: Bill Wexler who wrote (1782)	7/10/1999 2:44:00 PM
From: Mike M	Read Replies (1) \| Respond to of 10293

ZICAM is a "homeopathic" remedy (i.e. quack medicine - kind of reminds me a bit of QGLY). Have you ever used the product or are you basing this on the vast part of your knowledge exclusive of experience?